IGF2BP3 Associates with Proliferative Phenotype and Prognostic Features in B-Cell Acute Lymphoblastic Leukemia
Open Access
Abstract
The oncofetal protein insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) belongs to a family of RNA-binding proteins involved in localization, stability, and translational regulation of target RNAs. IGF2BP3 is used as a diagnostic and prognostic marker in several malignancies. Although the prognosis of pediatric B-cell acute lymphoblastic leukemia (B-ALL) has improved, a subgroup of patients exhibits high-risk features and suffer from disease recurrence. We sought to identify additional biomarkers to improve diagnostics, and we assessed expression of IGF2BP3 in a population-based pediatric cohort of B-ALL using a tissue microarray platform. The majority of pediatric B-ALL cases were positive for IGF2BP3 immunohistochemistry and were associated with an increased proliferative phenotype and activated STAT5 signaling pathway. Two large gene expression data sets were probed for the expression of IGF2BP3—the highest levels were seen among the B-cell lymphomas of a germinal center origin and well-established (KMT2A-rearranged and ETV6-RUNX1) and novel subtypes of B-ALL (e.g., NUTM1 and ETV6-RUNX1-like). A high mRNA for IGF2BP3 was associated with a proliferative “metagene” signature and a high expression of CDK6 in B-ALL. A low expression portended inferior survival in a high-risk cohort of pediatric B-ALL. Overall, our results show that IGF2BP3 shows subtype-specificity in expression and provides prognostic utility in high-risk B-ALL.Keywords
Funding Information
- Competitive State Research Financing of the Expert Responsibility at Tampere University Hospi-tal (9X027)
- Research Council of Finland (277816, 310106)
- Sigrid Juselius Foundation (-)
- Syöpäjärjestöt (-)
- Jane ja Aatos Erkon Säätiö (-)
- Väre Foundation for Paediatric Cancer Research (-)
This publication has 37 references indexed in Scilit:
- Self-Enforcing Feedback Activation between BCL6 and Pre-B Cell Receptor Signaling Defines a Distinct Subtype of Acute Lymphoblastic LeukemiaCancer Cell, 2015
- The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancerSeminars in Cancer Biology, 2014
- Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2014
- Acute lymphoblastic leukaemiaThe Lancet, 2013
- Increased tumor cell proliferation in mantle cell lymphoma is associated with elevated insulin-like growth factor 2 mRNA-binding protein 3 expressionLaboratory Investigation, 2012
- RNA-binding Protein Insulin-like Growth Factor mRNA-binding Protein 3 (IMP-3) Promotes Cell Survival via Insulin-like Growth Factor II Signaling after Ionizing RadiationJournal of Biological Chemistry, 2011
- Identification of characteristic IGF2BP expression patterns in distinct B-ALL entitiesBlood Cells, Molecules, and Diseases, 2011
- Common markers of proliferationNature Reviews Cancer, 2006
- The RNA-binding Protein IMP-3 Is a Translational Activator of Insulin-like Growth Factor II Leader-3 mRNA during Proliferation of Human K562 Leukemia CellsJournal of Biological Chemistry, 2005
- Characterisation of the growth regulating gene IMP3, a candidate for Silver-Russell syndromeJournal of Medical Genetics, 2002